Clinical Trials Logo

Arthropathy of Knee clinical trials

View clinical trials related to Arthropathy of Knee.

Filter by:
  • Enrolling by invitation  
  • Page 1

NCT ID: NCT05770934 Enrolling by invitation - Clinical trials for Osteoarthritis, Knee

Late-initiated Blood Flow Restricted Rehabilitation Exercises After Total Knee Replacement

EXKnee2
Start date: April 12, 2023
Phase: N/A
Study type: Interventional

This trial will investigate the effectiveness of applying low-load blood flow restricted exercise 12 months after receiving a total knee replacement to achieve a functional capacity-level similar to healthy peers. Participants will be allocated to either an exercise group performing a sit-to-stand exercise 4/weekly with concurrent partial restriction of the blood flow to the limbs or a usual care.

NCT ID: NCT03674697 Enrolling by invitation - Acute Pain Clinical Trials

The Effect of Light Therapy on Post-Surgical Pain

Start date: December 1, 2024
Phase: N/A
Study type: Interventional

This is a prospective randomized clinical trial study to investigate two main aspects. The first aspect is to investigate the efficacy exposure to green light emitting diode (GLED) in reducing postoperative opioid medications requirements by 20% as the primary outcome amongst patients scheduled for elective total knee replacement surgery (knee arthroplasty). The second aspect is to reduce postoperative pain by 30%, improve preoperative anxiety by 30%, and improve the quality of sleep pre and postoperatively by 30%. Seventy participants scheduled for elective unilateral primary total knee arthroplasty (total knee replacement) will be recruited from the pain clinic or from the orthopedic surgery clinics at Banner-University Medical Center by the pain or orthopedic physicians who are key personnel of this study. Once a participant is identified, he/she will meet with one of the research team members to explain the nature of the clinical trial and undergo a standard of care medical history gathering and baseline physical examinations. If the participant meets all the inclusion and have no exclusion criteria, he/she will be presented with a written consent in English to explain all the risk and benefits of this clinical trial. Once a participant signs a consent, he or she will be randomized by the study statistician, in a 1:1 ratio to either a GLED group (treatment) or white light-emitting diode (WLED) group (control). The participant will be trained on how to use the light device by one of the research team members. All participants will be exposed to either GLED or WLED for 8 weeks prior to surgery and two additional weeks after surgery.